“It’s better to learn from others’ mistakes than from your own—because it’s faster, less painful, and usually well documented. That’s […]
$19 Billion Lesson from Berkshire Hathaway’s Dexter Shoes Mistake Read Post »
I recently had some good fortune with a few moonshot stocks gaining between 40% and 100%. A common question arises:
After-Trim Rules: Managing Stocks With Discipline and Flexibility Read Post »
In less than five months, Flight To Wealth has rapidly gained recognition across major search engines, now seen as the
Flight To Wealth: Officially Recognized by Google and Bing Read Post »
The recent Chase case and the high-profile Charlie Javice / Frank acquisition highlight how even large, sophisticated organizations can face
A renowned marine biologist was recently bitten on the head while tagging a shark nearly 140 feet deep off Costa
Flight to Wealth: Diving Into Risk: Why It’s Okay Not to Take Every Risk Read Post »
Earning 3% cash back on everyday spending is the holy grail for credit card rewards—but these cards are surprisingly rare.
Introduction Moonshot stocks represent tantalizing opportunities—biotech breakthroughs, AI innovators, early-stage disruptors—with the potential to reshape portfolios. But beyond the dream
Smart Moonshots: Capture High Upside While Limiting Risk | Flight to Wealth Read Post »
Portfolio Overview I started tracking and building this moonshot portfolio in June 2025, focusing on high-conviction biotech, semiconductor, and select
Moonshot Portfolio Update — September 26, 2025 Read Post »
I first bought Crinetics Pharmaceuticals (CRNX) in June this year at an average cost of $31.86. From the start, it
CRNX Case Study: Action after FDA Approval Read Post »
For years, I only associated Robinhood with its reputation for frequent trading and the meme-stock craze. It wasn’t a platform
Robinhood Gold & Roth IRA Match — Is It Worth It? Read Post »
